Bestaande gebruiker? Log in
Abonneren
Home
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Analisten vandaag
Meest aanbevolen aandelen
Minst aanbevolen aandelen
Aandelen met grootste potentieel
Insider trading
Insiders vandaag
Meest gekochte aandelen
Meest verkochte aandelen
Mijn Trivano
Mijn Trivano
Mijn selecties
Mijn nieuwsbrieven
Abonneren
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Insider trading
Mijn Trivano
Registreren / inloggen
Beurs vandaag
Amerika
Evogene Ltd.
Nieuws
Evogene Ltd.
EVGN
NAS
: EVGN
| ISIN: IL0011050551
13/05/2024
0,681 USD
(-0,84%)
(-0,84%)
13/05/2024
Aandeel volgen
Aandeel gevolgd
Samenvatting
Nieuws
Technische analyse
TA
Toon enkel gratis nieuws
9 mei 2024 ·
Evogene Schedules First Quarter 2024 Financial Results Release
· Persbericht
16 april 2024 ·
Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting
· Persbericht
11 april 2024 ·
Biomica to Present at Digestive Disease Week (DDW) Conference 2024 Annual Meeting
· Persbericht
2 april 2024 ·
Evogene and The Kitchen FoodTech Hub by Strauss Group Established Finally Foods Ltd. - Revolutionizing Protein Production in Plants for the Food Industry
· Persbericht
28 maart 2024 ·
Evogene Announces Filing of Annual Report on Form 20-F
· Persbericht
20 maart 2024 ·
Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification
· Persbericht
19 maart 2024 ·
Bayer AG and Lavie Bio Continue for Second Year of Biofungicides Validation Following Successful Lab and Greenhouse Testing
· Persbericht
13 maart 2024 ·
Lavie Bio and Ceres Global Ag Corp. Collaborate to Include YalosTM Bio-Inoculant, in Regenerative Agriculture Initiatives in North America
· Persbericht
7 maart 2024 ·
Evogene Reports Fourth Quarter and Full Year 2023 Financial Results
· Persbericht
6 maart 2024 ·
AgPlenus Achieves Milestone in Collaboration with Corteva to Develop Novel Herbicides
· Persbericht
5 maart 2024 ·
Casterra Announces New Agreements with Seed Producers in Brazil and Africa to Meet Growing Demand for its Elite Castor Seed Varieties
· Persbericht
28 februari 2024 ·
Lavie Bio Successfully Secures Second Half Advance Payment of $2.5M after Meeting Corteva's Licensing Agreement Requirements
· Persbericht
26 februari 2024 ·
Evogene Schedules Fourth Quarter 2023 Financial Results Release & Conference Call for March 7th, 2024
· Persbericht
22 februari 2024 ·
AgPlenus Announces Appointment of Dr. Dan Jacob Gelvan as its Incoming Chief Executive Officer
· Persbericht
21 februari 2024 ·
AgPlenus Announces Licensing & Collaboration Agreement with Bayer to Develop a New Sustainable Weed Control Solution
· Persbericht
20 februari 2024 ·
Syngenta and Lavie Bio Announce Partnership to Discover and Develop Novel Bio-Insecticide
· Persbericht
6 februari 2024 ·
Evogene and Verb Biotics Enter Collaboration Agreement to Advance Probiotic Innovation
· Persbericht
23 januari 2024 ·
Biomica CEO Set to Engage in Panel Discussion at 8th Annual European Microbiome Movement Summit
· Persbericht
17 januari 2024 ·
Biomica Successfully Completes Phase I Trial Enrollment for Microbiome-Based Immuno-Oncology Drug
· Persbericht
21 december 2023 ·
Biomica CEO Set to Attend JP Morgan Healthcare Week in San Francisco, January 8-11, 2024
· Persbericht
Aandeel volgen
Aandeel gevolgd
Mijn selecties
Voorbeeldselectie
Je selectie is nog leeg.
Voeg nu effecten toe